Home › Trial NCT00354978
Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients
- Trial IDNCT00354978
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorM.D. Anderson Cancer Center
- Enrollment49
- Start date2005-01
- ConditionsColorectal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.